A Systematic Review of Parkinson’s Disease Pharmacogenomics: Is There Time for Translation into the Clinics?

Background: Parkinson’s disease (PD) is the second most frequent neurodegenerative disease, which creates a significant public health burden. There is a challenge for the optimization of therapies since patients not only respond differently to current treatment options but also develop different sid...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuletić, Vladimira, Rački, Valentino, Papić, Eliša, Peterlin, Borut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268929/
https://www.ncbi.nlm.nih.gov/pubmed/34281267
http://dx.doi.org/10.3390/ijms22137213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268929/
https://www.ncbi.nlm.nih.gov/pubmed/34281267
http://dx.doi.org/10.3390/ijms22137213

Ejemplares similares